SCHEMBL6961237

SCHEMBL6961237

Cc1cccc(-c2cc(O)c(Sc3ccccc3C(C)C)c(=O)o2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 1/20 0.42
TP53 P04637 2/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RECQL P46063 1/20 0.36
SLC9A1 P19634 2/20 0.35
ABCB1 P08183 1/20 0.34
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959292 0.91 POLB (0.35) QPCTTP53CYP3A4MAPTMAPK1
SCHEMBL6964481 0.90 TNKS (0.44) TP53CYP3A4MAPTMAPK1KDM4E
SCHEMBL6961039 0.89 SMN1; SMN2 (0.46) TP53CYP3A4MAPTKDM4EALDH1A1
SCHEMBL6964073 0.88 AR (0.41) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL6963792 0.88 GABRP (0.43) MAPTKDM4ETDP1CA12CA9
SCHEMBL6959070 0.85 POLB (0.42) TP53CYP3A4MAPTKDM4EALDH1A1
SCHEMBL6960410 0.85 POLB (0.42) TP53CYP3A4MAPTKDM4EALDH1A1
SCHEMBL6958727 0.85 CYP1A2 (0.42) TP53MAPTKDM4EALDH1A1SLC9A1
SCHEMBL6963494 0.85 PTGES (0.43) QPCTTP53CYP3A4MAPTMAPK1
SCHEMBL6960294 0.84 QPCT (0.39) QPCTTP53MAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed